It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Formation of oriented myofibrils is a key event in musculoskeletal development. However, the mechanisms that drive myocyte orientation and fusion to control muscle directionality in adults remain enigmatic. Here, we demonstrate that the developing skeleton instructs the directional outgrowth of skeletal muscle and other soft tissues during limb and facial morphogenesis in zebrafish and mouse. Time-lapse live imaging reveals that during early craniofacial development, myoblasts condense into round clusters corresponding to future muscle groups. These clusters undergo oriented stretch and alignment during embryonic growth. Genetic perturbation of cartilage patterning or size disrupts the directionality and number of myofibrils in vivo. Laser ablation of musculoskeletal attachment points reveals tension imposed by cartilage expansion on the forming myofibers. Application of continuous tension using artificial attachment points, or stretchable membrane substrates, is sufficient to drive polarization of myocyte populations in vitro. Overall, this work outlines a biomechanical guidance mechanism that is potentially useful for engineering functional skeletal muscle.
The mechanisms that drive myocyte orientation and fusion to control muscle directionality are not well understood. Here authors show that the developing skeleton produces mechanical tension that instructs the directional outgrowth of skeletal muscles.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Fabry, Ben 2
; Adori, Csaba 3 ; Kameneva, Polina 4 ; Faure, Louis 4
; Kanatani, Shigeaki 5
; Kaucka, Marketa 6
; Dehnisch Ellström, Ivar 7 ; Tesarova, Marketa 8
; Zikmund, Tomas 8
; Kaiser, Jozef 8
; Edwards, Steven 9 ; Maki, Koichiro 10 ; Adachi, Taiji 10
; Yamamoto, Takuya 11 ; Fried, Kaj 12
; Adameyko, Igor 13
1 Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
2 University of Erlangen-Nuremberg, Department of Physics, Erlangen, Germany (GRID:grid.5330.5) (ISNI:0000 0001 2107 3311)
3 Karolinska Institutet, Department of Neuroscience, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Stockholm University, Department of Molecular Biosciences, Wenner Gren Institute, Stockholm, Sweden (GRID:grid.10548.38) (ISNI:0000 0004 1936 9377)
4 Medical University Vienna, Department of Neuroimmunology, Center for Brain Research, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)
5 Karolinska Institutet, Department of Medical Biochemistry and Biophysics, Division of Molecular Neurobiology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
6 Max Planck Institute for Evolutionary Biology, Plön, Germany (GRID:grid.419520.b) (ISNI:0000 0001 2222 4708)
7 Spinalis Foundation, Solna, Sweden (GRID:grid.419520.b)
8 Brno University of Technology, Central European Institute of Technology, Brno, Czech Republic (GRID:grid.4994.0) (ISNI:0000 0001 0118 0988)
9 KTH Royal Institute of Technology, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746)
10 Kyoto University, Laboratory of Biomechanics, Institute for Life and Medical Sciences, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
11 Kyoto University, Institute for the Advanced Study of Human Biology (ASHBi), Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033); Kyoto University, Center for iPS Cell Research and Application (CiRA), Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
12 Karolinska Institutet, Department of Neuroscience, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
13 Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Medical University Vienna, Department of Neuroimmunology, Center for Brain Research, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)




